SLC16A5-KCTD2 Fusion FISH Probe
The SLC16A5-KCTD2 Fusion FISH Probe is used to confirm a fusion of the SLC16A5 and KCTD2 genes. The fusion of the SLC16A5 and KCTD2 genes has been associated with Skin Cutaneous Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SLC16A5-KCTD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SLC16A5-KCTD2-20-AQAQ | 20 (40 μL) | 200 μL |
|
SLC16A5 Gene Summary
This gene encodes a member of the monocarboxylate transporter family and the major facilitator superfamily. The encoded protein is localized to the cell membrane and acts as a proton-linked transporter of bumetanide. Transport by the encoded protein is inhibited by four loop diuretics, nateglinide, thiazides, probenecid, and glibenclamide. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2012]
Gene Name: Solute Carrier Family 16 Member 5
Chromosome: CHR17: 73084054 -73102248
Locus: 17q25.1
KCTD2 Gene Summary
The Potassium Channel Tetramerization Domain Containing 2 (KCTD2) gene is located on chr17 :73043278-73061981 at 17q25.1.
Gene Name: Potassium Channel Tetramerization Domain Containing 2
Chromosome: CHR17: 73043278 -73061981
Locus: 17q25.1
Gene Diseases
The SLC16A5 KCTD2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Skin Cutaneous Melanoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|